SINCE LAST FALLāS SUCCESSFUL IPOs (initial public offering) raised $92 million for Specialty Laboratories, Inc. and $50 million for Dynacare, Inc., the financial fortunes of the two lab companies have begun moving in different directions. Lab administrators and pathologists can better understand the diverging business directions of Specialty Labs and Dynacare by studying each labās […]
To access this post, you must purchase The Dark Report.